Today: 20 May 2026
Browse Category

NASDAQ:UWMC 17 December 2025 - 9 January 2026

UWMC stock jumps on Trump’s $200 billion mortgage-bond order as traders hunt for proof rates will fall

UWMC stock jumps on Trump’s $200 billion mortgage-bond order as traders hunt for proof rates will fall

UWM Holdings shares surged 14% to $5.36 Friday after President Trump ordered $200 billion in mortgage-bond purchases to lower borrowing costs. Over 22 million shares traded. CEO Mat Ishbia’s SFS Holding sold nearly 1.9 million shares earlier in the week at $4.43–$4.70. Investors await inflation and mortgage-rate data for further direction.
9 January 2026
··
Mortgage rates today: Trump’s $200B bond order lifts Rocket Companies stock, loanDepot premarket

Mortgage rates today: Trump’s $200B bond order lifts Rocket Companies stock, loanDepot premarket

President Donald Trump ordered a $200 billion purchase of mortgage-backed securities, sending Rocket Companies up 6.45% and loanDepot up 18.85% in premarket trading. Freddie Mac reported the average 30-year fixed mortgage rate at 6.16% for the week ended Jan. 8. Traders await the 8:30 a.m. ET U.S. jobs report.
9 January 2026
·····
TWO-PB Stock Today: Two Harbors Series B Preferred Jumps After UWM’s $1.3B Acquisition Deal — Dividend Outlook, Exchange Terms, and Key Risks

TWO-PB Stock Today: Two Harbors Series B Preferred Jumps After UWM’s $1.3B Acquisition Deal — Dividend Outlook, Exchange Terms, and Key Risks

UWM Holdings and Two Harbors Investment Corp. announced a $1.3 billion all-stock merger on December 17, 2025. Two Harbors Series B preferred shares (TWO-PB) will be exchanged one-for-one for new UWMC preferred shares, according to a Form 8-K. The deal is expected to close in Q2 2026, pending approvals. Two Harbors brings a $176 billion mortgage servicing portfolio to the combined company.
17 December 2025
····
1 2

Stock Market Today

  • Parabilis Plans IPO to Fund Phase 3 Trial for Tumor Drug Following Regeneron Deal
    May 20, 2026, 5:56 AM EDT. Parabilis Medicines, a Massachusetts biotech, is preparing for an initial public offering (IPO) to finance the phase 3 trial of its tumor drug zolucatetide, targeting rare desmoid tumors. The drug, which inhibits the Wnt/β-catenin pathway implicated in many cancers, recently received FDA fast-track status. Proceeds will also support phase 1 trials for additional cancers. Parabilis secured a $50 million upfront payment and a $75 million equity investment from Regeneron in a deal to explore Parabilis' helicon peptide platform. The firm boasts over $300 million in cash from prior funding rounds. CEO Mathai Mammen aims to grow Parabilis into a fully integrated research, development, manufacturing, and commercialization company, relying on partnerships to finance its ambitions.

Latest articles

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

20 May 2026
OCI Energy and CPS Energy have begun building a 120-megawatt battery storage facility in southeastern Bexar County, aiming for commercial operation in 2027. The project follows a rise in average outage duration for CPS Energy customers to 75.38 minutes in 2025. OCI will own the facility, with CPS holding operational control. ING is financing construction, and LG Energy Solution Vertech is supplying batteries.
Co-Diagnostics Jumps; $3 Million Deal Looms

Co-Diagnostics Jumps; $3 Million Deal Looms

20 May 2026
Co-Diagnostics announced a $3 million private placement after its stock surged 43.8% Tuesday, then fell 13.3% in after-hours trading. The company will sell 1.65 million shares or pre-funded warrants, plus warrants for up to 3.29 million more shares, nearly doubling its share count. The move follows its completion of a Bundibugyo virus assay as Ebola spreads in Congo and Uganda. Co-Diagnostics reported $8.2 million in cash at March 31.
Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

20 May 2026
Micron Technology shares rose 2.5% Tuesday to $698.74, lifting its market value near $798 billion as the Nasdaq fell. Analysts cited tight memory supply and strong DRAM and NAND pricing. A planned strike by 48,000 Samsung workers Thursday could disrupt global memory supply, potentially raising prices. Micron recently sampled 256GB DDR5 server modules to partners.
Go toTop